shuterstock-171645473

Vaclav Mach / Shutterstock.com

27 November 2014Big PharmaGabriel Di Blasi and Mellina Mamede

IP in Brazil: breaking down barriers

Although Brazil has been ranked by the World Bank as the world’s seventh biggest economy, and is able to develop great technology, especially due to its extensive biodiversity, it has not become self-sufficient in the life sciences field.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

GSK triumphs in EPO appeal, revoking Pfizer patent

Teva fights for re-listing of inhaler patents at US appeals court

White & Case hires experienced litigator from A&O Shearman

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst